Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future
Molecular biomarkers are central to personalised medicine for human cancer patients.It is gaining traction as part of standard veterinary clinical practice for dogs and cats with cancer.Molecular biomarkers can be somatic or germline genomic alterations and can be ascertained from tissues or body fluids using various techniques.This review discusse